News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,356 Results
Type
Article (12827)
Company Profile (43)
Press Release (296485)
Multimedia
Podcasts (10)
Webinars (3)
Section
Business (84288)
Career Advice (483)
Deals (17659)
Drug Delivery (35)
Drug Development (41215)
Employer Resources (34)
FDA (8069)
Job Trends (6619)
News (153532)
Policy (14959)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (1116)
Academic (1)
Accelerated approval (16)
Adcomms (8)
Allergies (74)
Alliances (21888)
ALS (79)
Alzheimer's disease (869)
Antibody-drug conjugate (ADC) (180)
Approvals (8356)
Artificial intelligence (246)
Autoimmune disease (79)
Automation (24)
Bankruptcy (161)
Best Places to Work (5649)
BIOSECURE Act (3)
Biosimilars (67)
Biotechnology (33)
Bladder cancer (123)
Brain cancer (39)
Breast cancer (358)
Cancer (3058)
Cardiovascular disease (188)
Career advice (437)
Career pathing (7)
CAR-T (192)
CDC (11)
Celiac Disease (2)
Cell therapy (443)
Cervical cancer (26)
Clinical research (36663)
Collaboration (829)
Company closure (1)
Compensation (207)
Complete response letters (22)
COVID-19 (1177)
CRISPR (46)
C-suite (354)
Cystic fibrosis (70)
Data (4151)
Denatured (5)
Depression (61)
Diabetes (207)
Diagnostics (4529)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (117)
Drug pricing (61)
Drug shortages (20)
Duchenne muscular dystrophy (121)
Earnings (40262)
Editorial (20)
Employer branding (4)
Employer resources (27)
Events (40419)
Executive appointments (442)
FDA (10051)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (682)
Gene editing (103)
Generative AI (21)
Gene therapy (296)
GLP-1 (351)
Government (1858)
Grass and pollen (3)
Guidances (300)
Healthcare (7711)
HIV (36)
Huntington's disease (16)
IgA nephropathy (55)
Immunology and inflammation (86)
Immuno-oncology (27)
Indications (71)
Infectious disease (1319)
Inflammatory bowel disease (93)
Inflation Reduction Act (6)
Influenza (67)
Intellectual property (171)
Interviews (69)
IPO (8806)
IRA (20)
Job creations (1249)
Job search strategy (379)
JPM (14)
Kidney cancer (12)
Labor market (19)
Layoffs (80)
Leadership (8)
Legal (2880)
Liver cancer (57)
Longevity (3)
Lung cancer (413)
Lymphoma (254)
Machine learning (21)
Management (9)
Manufacturing (367)
MASH (100)
Medical device (5729)
Medtech (5754)
Mergers & acquisitions (9567)
Metabolic disorders (532)
Multiple sclerosis (89)
NASH (9)
Neurodegenerative disease (132)
Neuropsychiatric disorders (34)
Neuroscience (1453)
NextGen: Class of 2026 (2134)
Non-profit (1192)
Now hiring (14)
Obesity (222)
Opinion (117)
Ovarian cancer (118)
Pain (100)
Pancreatic cancer (156)
Parkinson's disease (132)
Partnered (15)
Patents (322)
Patient recruitment (306)
Peanut (23)
People (22279)
Pharmaceutical (13)
Pharmacy benefit managers (9)
Phase 1 (11711)
Phase 2 (16011)
Phase 3 (12147)
Pipeline (3516)
Policy (77)
Postmarket research (1041)
Preclinical (4689)
Press Release (26)
Prostate cancer (141)
Psychedelics (15)
Radiopharmaceuticals (151)
Rare diseases (418)
Real estate (2689)
Recruiting (11)
Regulatory (12582)
Reports (19)
Research institute (1040)
Resumes & cover letters (56)
Rett syndrome (22)
RNA editing (5)
RSV (33)
Schizophrenia (75)
Series A (108)
Series B (84)
Service/supplier (2)
Sickle cell disease (51)
Special edition (2)
Spinal muscular atrophy (61)
Sponsored (22)
Startups (1172)
State (1)
Stomach cancer (8)
Supply chain (52)
Tariffs (13)
The Weekly (4)
Vaccines (339)
Venture capital (18)
Weight loss (118)
Women's health (34)
Worklife (5)
Date
Today (10)
Last 7 days (312)
Last 30 days (1242)
Last 365 days (16640)
2026 (1526)
2025 (16731)
2024 (19193)
2023 (21884)
2022 (27454)
2021 (28920)
2020 (27176)
2019 (18616)
2018 (13913)
2017 (14887)
2016 (13283)
2015 (15617)
2014 (11340)
2013 (9048)
2012 (9329)
2011 (10109)
2010 (9209)
Location
Africa (274)
Alabama (38)
Alaska (3)
Arizona (97)
Arkansas (5)
Asia (22101)
Australia (5457)
California (6210)
Canada (1990)
China (587)
Colorado (257)
Connecticut (317)
Delaware (156)
Europe (39508)
Florida (972)
Georgia (128)
Hawaii (1)
Idaho (12)
Illinois (413)
India (54)
Indiana (254)
Iowa (2)
Japan (253)
Kansas (43)
Kentucky (16)
Louisiana (14)
Maine (63)
Maryland (727)
Massachusetts (4298)
Michigan (173)
Minnesota (231)
Missouri (87)
Montana (21)
Nebraska (10)
Nevada (84)
New Hampshire (51)
New Jersey (1971)
New Mexico (11)
New York (1828)
North Carolina (739)
North Dakota (3)
Northern California (3017)
Ohio (170)
Oklahoma (5)
Oregon (12)
Pennsylvania (1204)
Puerto Rico (11)
Rhode Island (17)
South America (443)
South Carolina (46)
Southern California (2479)
Tennessee (79)
Texas (1065)
United States (22035)
Utah (162)
Virginia (146)
Washington D.C. (24)
Washington State (580)
West Virginia (2)
Wisconsin (38)
Wyoming (1)
309,356 Results for "ranbaxy laboratories limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AABB To Run Limited-Time Certified Advanced Biotherapies Professional (CABP) Free Exam Retake Offer
December 1, 2025
·
1 min read
Press Releases
Haemonetics Acquires Vivasure Medical Limited
January 9, 2026
·
5 min read
Press Releases
Charles River Laboratories Provides Business Updates
January 13, 2026
·
14 min read
Press Releases
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026
·
4 min read
Press Releases
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
January 5, 2026
·
9 min read
Press Releases
Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus
January 28, 2026
·
3 min read
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY26
January 29, 2026
·
7 min read
Press Releases
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
February 6, 2026
·
4 min read
Press Releases
Deutsche Bank Appointed as Successor Depositary Bank for the American Depositary Receipt Program of CSL Limited
January 28, 2026
·
2 min read
Opinion
Fate of FDA’s Laboratory-Developed Testing Final Rule Hints at
Chevron
Overturn’s Ramifications
In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency authority, a judge ruled that the FDA does not have authority to regulate tests developed by clinical laboratories.
September 29, 2025
·
4 min read
·
Megan Robertson
1 of 30,936
Next
